NuCana plc (NASDAQ: NCNA) announced financial results for the fourth quarter and year ended December 31, 2024 and provided an update on its clinical development program with its two lead anti-cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback